Coral Laboratories tumbled 17.29% to Rs 780 at 14:38 IST on BSE after net profit fell 57.92% to Rs 2.12 crore on 22.19% drop in total income to Rs 20.49 crore in Q3 December 2017 over Q3 December 2016.
The result was announced during market hours today, 25 January 2018.Meanwhile, the S&P BSE Sensex was down 185.73 points or 0.51% at 35,975.91. The S&P BSE Small-Cap index was down 102.14 points or 0.52% at 19,372.85, underperforming the Sensex.
More than usual volumes were witnessed on the counter. On the BSE, 5,880 shares were traded on the counter so far as against average daily volumes of 1,750 shares in the past one quarter.
The stock had hit a high of Rs 959.95 and a low of Rs 780 so far during the day. The stock had hit a record high of Rs 1,190 on 25 July 2017. The stock had hit a 52-week low of Rs 566 on 2 February 2017.
The small-cap company has equity capital of Rs 3.57 crore. Face value per share is Rs 10.
Coral Laboratories is a pharma firm and is equipped with an ultra modern strategically spread manufacturing units located in Daman, Dehradun and Vasai.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)